Bio-Techne (TECH) Liabilities and Shareholders Equity (2009 - 2026)

Bio-Techne's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $2.6 billion for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 3.54% year-over-year to $2.6 billion in Q1 2026; TTM through Mar 2026 was $10.2 billion, a 5.55% decrease from a year earlier, with the FY2025 full-year figure at $2.6 billion, down 5.4% from the prior year.
• Liabilities and Shareholders Equity climbed to $2.6 billion in Q1 2026 per TECH's latest filing, from $2.5 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.8 billion in Q3 2023 and bottomed at $2.3 billion in Q2 2022.
• The 5-year median for Liabilities and Shareholders Equity is $2.6 billion (2023), against an average of $2.6 billion.
• Across the five-year window, Liabilities and Shareholders Equity increased 17.21% in 2023 and decreased 7.67% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $2.4 billion in 2022, then climbed by 15.54% to $2.7 billion in 2023, then fell by 2.21% to $2.7 billion in 2024, then retreated by 5.53% to $2.5 billion in 2025, then rose by 1.11% to $2.6 billion in 2026.
• Per Business Quant, the three latest TECH Liabilities and Shareholders Equity figures stand at $2.6 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025).